Home - Products - Others - Other Targets - Obtusifolin 2-O-β-D-glucoside

Obtusifolin 2-O-β-D-glucoside

CAS No. 120163-18-0

Obtusifolin 2-O-β-D-glucoside( ——— )

Catalog No. M38237 CAS No. 120163-18-0

Obtusifolin-2-O-glucoside (compound 7) is a Tyrosinase inhibitor (IC50=9.2 μM). Obtusifolin-2-O-glucoside can be isolated from cassia seed.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Obtusifolin 2-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Obtusifolin-2-O-glucoside (compound 7) is a Tyrosinase inhibitor (IC50=9.2 μM). Obtusifolin-2-O-glucoside can be isolated from cassia seed.
  • Description
    Obtusifolin-2-O-glucoside (compound 7) is a Tyrosinase inhibitor (IC50=9.2 μM). Obtusifolin-2-O-glucoside can be isolated from cassia seed.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: 9.2 μM (Tyrosinase)
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    120163-18-0
  • Formula Weight
    446.4
  • Molecular Formula
    C22H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee GY, et al. Tyrosinase inhibitory components from the seeds of Cassia tora. Arch Pharm Res. 2018 May;41(5):490-496. ?
molnova catalog
related products
  • Benfotiamine

    Benfotiamine, the lipid-soluble thiamine derivative used as a treatment for diabetic neuropathy.

  • L-ABRINE

    L-ABRINE is a toxic protein found in the jequirity seed.can be used as a biomarker for abrin exposure.

  • E-3030

    E-3030 free acid is a potent dual activator of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma, exhibiting significant antidiabetic and lipid-modulating effects. E-3030 decreases blood glucose, triglyceride, non-esterified fatty acids, and insulin levels, while increasing blood adiponectin levels. E-3030 improves glucose tolerance and shows remarkable triglyceride- and non-high-density lipoprotein cholesterol-lowering effects in animal models.